XW01318
XW01318
is a valid billable ICD-10 procedure code for Introduction of Daratumumab and Hyaluronidase-fihj into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 8.
It is found in the 2025 version of the ICD-10 Procedure Coding System (PCS) and can be used in all HIPAA-covered transactions from Oct 01, 2024 - Sep 30, 2025.
Introduction involves:
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
Percutaneous approach involves:
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure
ICD-10-PCS code structure for XW01318
— See Table View
1: Section | X |
New Technology |
---|---|---|
2: Body System | W |
Anatomical Regions |
3: Root Operation | 0 |
Introduction |
4: Body Part | 1 |
Subcutaneous Tissue |
5: Approach | 3 |
Percutaneous |
6: Device | 1 |
Eladocagene exuparvovec |
7: Qualifier | 8 |
New Technology Group 8 |
See also